Prohibits acquisition or disclosure of certain personal health information without consent.
Impact
The bill adds an important layer of protection for residents' health data, mirroring and supplementing existing protections under the Health Insurance Portability and Accountability Act of 1996 (HIPAA). It seeks to prevent unauthorized access to personal health data by ensuring that consent is obtained both for the initial acquisition and each subsequent disclosure. This change is seen as particularly relevant given the growing reliance on mobile applications and wearable devices for health monitoring, which often aggregate sensitive information. Critics may argue that while the intentions are good, there may be challenges in implementation and compliance, especially for smaller health care providers and app developers.
Summary
Assembly Bill A1419 seeks to establish stronger protections around the acquisition and disclosure of personal health information in the State of New Jersey. Specifically, the bill mandates that health care providers, mobile application developers, and third parties must obtain explicit consent from individuals before acquiring or disclosing their biometric, health, or protected health information. This requirement is aimed at enhancing privacy rights in an era where data breaches and unauthorized data usage are prevalent. The bill's text emphasizes that each disclosure will require a separate and distinct grant of consent, reinforcing individual control over their sensitive information.
Contention
A significant point of contention surrounding A1419 is the potential burden it places on health care providers and innovators in the health technology space. Some stakeholders might express concerns about the feasibility and administrative challenges associated with obtaining frequent consent, particularly in urgent care situations where rapid access to patient data is necessary. Furthermore, given that the bill allows for private rights of action with damages set at $1,000 per violation, there are apprehensions regarding the implications this may have on health care practices and technological entrepreneurship within the state.